Los Angeles [US], June 19 (ANI): According to the researchers at the University of Pennsylvania, synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo or radiation.
Los Angeles [US], June 19 (ANI): According to UCLA scientists working with Stanford and University of Pennsylvania experts, a synthetic IL-9 receptor permits cancer-fighting T cells to accomplish their job without the usage of chemo or radiation.
Los Angeles [US], June 17 (ANI): According to a team led by UCLA in collaboration with scientists from Stanford and the University of Pennsylvania, has demonstrated that a synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo or radiation.
Washington [US], June 12 (ANI): A new study has found that a patient can undergo T cell therapy designed to target cancerous tumours, the patient's entire immune system must be destroyed with chemotherapy or radiation.
Washington [US], June 9 (ANI): According to a study by the University of California-Los Angeles Health Science, before a patient can undergo T cell therapy designed to target cancerous tumours, the patient's entire immune system must be destroyed with chemotherapy or radiation.